Biblio

Export 91 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is B  [Clear All Filters]
2015
N. Voyle, Baker, D., Burnham, S. C., Covin, A., Zhang, Z., Sangurdekar, D. P., Hehir, C. A. Tan, Bazenet, C., Lovestone, S., Kiddle, S., and Dobson, R. J. B., “Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.”, J Alzheimers Dis, 2015.
J. Olazarán, Gil-de-Gómez, L., Rodríguez-Martín, A., Valentí-Soler, M., Frades-Payo, B., Marín-Muñoz, J., Antúnez, C., Frank-García, A., Jiménez, C. Acedo, Gracia, L. Morlén, Torregrossa, R. Petidier, Guisasola, M. Concepció, Bermejo-Pareja, F., Sánchez-Ferro, Á., Pérez-Martínez, D. A., Palomo, S. Manzano, Farquhar, R., Rábano, A., and Calero, M., “A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
H. Jang, Kim, J. Hun, Choi, S. Hye, Lee, Y., Hong, C. Hyung, Jeong, J. Hyang, Han, H. Jeong, Moon, S. Young, Park, K. Won, Han, S. - H., Park, K. Hyung, Kim, H. Jin, Na, D. L., and Seo, S. Won, “Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.”, J Alzheimers Dis, 2015.
W. R. Leifert, Nguyen, T., Rembach, A., Martins, R., Rainey-Smith, S., Masters, C. L., Ames, D., Rowe, C. C., S Macaulay, L., François, M., and Fenech, M. F., “Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 48, no. 2, pp. 443-52, 2015.
2016
J. Miklossy, “Bacterial Amyloid and DNA are Important Constituents of Senile Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile Plaques.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1459-73, 2016.
E. Pretorius, Bester, J., and Kell, D. B., “A Bacterial Component to Alzheimer's-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1237-56, 2016.
M. Pietto, Parra, M. A., Trujillo, N., Flores, F., García, A. M., Bustin, J., Richly, P., Manes, F., Lopera, F., Ibáñez, A., and Baez, S., “Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1325-40, 2016.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
C. Lee, “Best Linear Unbiased Prediction of Individual Polygenic Susceptibility to Sporadic Vascular Dementia.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1115-9, 2016.
M. G. Cavuoto, Ong, B., Pike, K. E., Nicholas, C. L., Bei, B., and Kinsella, G. J., “Better Objective Sleep Quality in Older Adults with High Subjective Memory Decline.”, J Alzheimers Dis, vol. 53, no. 3, pp. 943-53, 2016.
T. Dziedzic, Pera, J., Klimkowicz-Mrowiec, A., Mroczko, B., and Slowik, A., “Biochemical and Radiological Markers of Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 623-44, 2016.
S. Martire, Fuso, A., Mosca, L., Forte, E., Correani, V., Fontana, M., Scarpa, S., Maras, B., and d'Erme, M., “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
M. Hülsemann, Zafiu, C., Kühbach, K., Lühmann, N., Herrmann, Y., Peters, L., Linnartz, C., Willbold, J., Kravchenko, K., Kulawik, A., Willbold, S., Bannach, O., and Willbold, D., “Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 79-88, 2016.
A. Russu, Samtani, M. N., Xu, S., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Liu, E., H Brashear, R., Styren, S., and Hu, C., “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
A. Mishima, Nihashi, T., Ando, Y., Kawai, H., Kato, T., Ito, K., and Terasawa, T., “Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 161-74, 2016.
A. M. Fernandez, Hervas, R., Dominguez-Fraile, M., Garrido, V. Navarro, Gomez-Gutierrez, P., Vega, M., Vitorica, J., Perez, J. J., and Aleman, I. Torres, “Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
S. Westwood, Leoni, E., Hye, A., Lynham, S., Khondoker, M. R., Ashton, N. J., Kiddle, S. J., Baird, A. L., Sainz-Fuertes, R., Leung, R., Graf, J., Hehir, C. Tan, Baker, D., Cereda, C., Bazenet, C., Ward, M., Thambisetty, M., and Lovestone, S., “Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.”, J Alzheimers Dis, vol. 52, no. 2, pp. 561-72, 2016.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., “Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
W. Wang, Lu, L., Wu, Q. - Q., and Jia, J. - P., “Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1089-99, 2016.
H. - J. Kim, Im, H. Kyun, Kim, J., Han, J. - Y., de Leon, M., Deshpande, A., and Moon, W. - J., “Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
P. Caffarra, Ghetti, C., Ruffini, L., Spallazzi, M., Spotti, A., Barocco, F., Guzzo, C., Marchi, M., and Gardini, S., “Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 51, no. 1, pp. 27-31, 2016.
Y. Vermeiren, Janssens, J., Aerts, T., Martin, J. - J., Sieben, A., Van Dam, D., and De Deyn, P. P., “Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1079-96, 2016.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., “Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
E. L. Goldwaser, Acharya, N. K., Sarkar, A., Godsey, G., and Nagele, R. G., “Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 445-56, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., “Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.”, J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.

Pages